Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2005
11/10/2005WO2005106001A1 Methods and compositions for plant transformation
11/10/2005WO2005106000A1 Use of a gene coding for the c4bp protein ? chain for producing recombinant dimeric proteins
11/10/2005WO2005105999A1 Improved method for the production of vitamin b12
11/10/2005WO2005105998A1 HUMAN ANTIAMYLOID β PEPTIDE ANTIBODY AND ANTIBODY FRAGMENT THEREOF
11/10/2005WO2005105997A1 Connexin 40 tissue specific gene mutations
11/10/2005WO2005105996A1 A pax-encoding vector and use thereof
11/10/2005WO2005105995A2 RNA INTERFERENCE MEDIATED TREATMENT OF POLYGLUTAMINE (POLYQ) REPEAT EXPANSION DISEASES USING SHORT INTERFERING NUCLEIC ACID (siNA)
11/10/2005WO2005105994A1 Method of disulfide crosslink forming type in vitro protein synthesis
11/10/2005WO2005105993A1 Hla-binding peptide, precursor thereof, dna fragment encoding the same and recombinant vector
11/10/2005WO2005105992A1 Chondrocyte culture formulations
11/10/2005WO2005105991A1 Amp deaminase originating in streptomyces and utilization thereof
11/10/2005WO2005105984A2 Culture conditions and growth factors affecting fate determination, self-renewal and expansion of mouse spermatogonial stem cells
11/10/2005WO2005105846A1 Antibody specifically recognizing resin plasticizer compound
11/10/2005WO2005105840A2 Cd40 variants and uses thereof
11/10/2005WO2005105838A2 Ion channel
11/10/2005WO2005105836A2 Methods and materials for improving plant drought tolerance
11/10/2005WO2005105833A2 Novel herpes simplex viruses and uses thereof
11/10/2005WO2005105157A2 INHIBITION OF HAIRLESS PROTEIN mRNA
11/10/2005WO2005105155A1 Methods for delivering a gene product to the eye
11/10/2005WO2005105152A2 Lipids, lipid complexes and use thereof
11/10/2005WO2005105144A1 LATENT TGF-β ACTIVATION INHIBITOR
11/10/2005WO2005105142A2 Recombinant reverse transcriptases
11/10/2005WO2005105136A1 Nanogene therapy for cell proliferation disorders
11/10/2005WO2005105130A1 Novel therapeutic usage of factor derived from pigment epithelium, capable of inhibiting nadph oxidase activity
11/10/2005WO2005104839A1 METHOD OF PROTECTING ORGAN BY TRANSFERRING Bcl-xL GENE
11/10/2005WO2005104836A2 Drosophila models for diseases affecting learning and memory
11/10/2005WO2005104835A2 Transgenic animals and uses thereof
11/10/2005WO2005104823A2 Shade responsive promoter, promoter control elements, and combinations and uses thereof
11/10/2005WO2005104822A1 Transgenic maize plants having enhanced nutritional qualities
11/10/2005WO2005087810A3 Dimeric fusion proteins and materials and methods for producing them
11/10/2005WO2005084210A3 Multiplex detection probes
11/10/2005WO2005083086A3 Epha4 as therapeutic target of prc and pdaca
11/10/2005WO2005083053A3 Method for producing unsaturated omega-3 fatty acids in transgenic organisms
11/10/2005WO2005082932A3 Compositions and methods using rna interference for control of nematodes in plants
11/10/2005WO2005078109A3 Expression of plasminogen and microplasminogen in duckweed
11/10/2005WO2005075637A3 Screening assays
11/10/2005WO2005075632A3 Treatment of neurodegenerative diseases by the use of atp7a-modulators
11/10/2005WO2005073381A3 Method for overproducing a specific recombinant protein with p. cinnabarinus monokaryotic strains
11/10/2005WO2005066348A3 Interleukin-12 targeted to oncofoetal fibronectin
11/10/2005WO2005063170A3 Methods of identifying immunoregulatory agents, immunoregulatory agents, and uses thereof
11/10/2005WO2005030259A3 Nucleic acid-lipophilic conjugates
11/10/2005WO2005026374A3 Method for synthesizing nucleic acids, and application thereof
11/10/2005WO2005024058A3 Compounds for the treatment of diseases involving cognitive impairment, such as alzheimer’s disease, and methods for identifying such compounds
11/10/2005WO2005014782B1 Double-stranded ribonucleic acid with increased effectiveness in an organism
11/10/2005WO2005014779A3 Cyclodextrin affinity purification
11/10/2005WO2005007691A8 East coast fever vaccine based on ctl-specific schizont antigens
11/10/2005WO2004113499A3 Modulation of flowering time by the pft1 locus
11/10/2005WO2004075842A3 Mrp3 genes and uses thereof
11/10/2005WO2004063963A3 Novel proteins with altered immunogenicity
11/10/2005WO2004035797A3 Tissue-specific promoters from plants
11/10/2005WO2004035743A3 Site specific incorporation of keto amino acids into proteins
11/10/2005WO2004016754A3 ANTISENSE MODULATION OF Nav1.3 EXPRESSION
11/10/2005WO2003101176A8 Method, composition and kit for antigenic binding of norwalk-like viruses
11/10/2005US20050251885 Method for enhancing yield of recombinant protein production from plants
11/10/2005US20050251884 Generation of multiple embryo maize
11/10/2005US20050251883 Dwarfism genes and dwarf plants
11/10/2005US20050251882 Sucrose phosphate synthase nucleic acid molecules and uses therefor
11/10/2005US20050251881 Carotenoid ketolase gene
11/10/2005US20050251880 Methods and compositions for regulating plant stress tolerance
11/10/2005US20050251879 Method for the production of transgenic plants with increased virus resistance by silencing vegetable DnaJ-like proteins
11/10/2005US20050251878 DNA sequences from photorhabdus luminescens
11/10/2005US20050251877 Methods and means for obtaining modified phenotypes
11/10/2005US20050251876 Aspartate kinase
11/10/2005US20050251875 Transgenic plants with tocopherol methyltransferase
11/10/2005US20050251874 Mice lacking alpha 1G showing enhanced novelty-seeking and alcohol preference and therapeutic methods for mood disorders by modulating alpha 1G T-type calcium channels
11/10/2005US20050251873 Ace2 activation for treatment of heart, lung and kidney disease and hypertension
11/10/2005US20050251872 Lentiviral vectors, related reagents, and methods of use thereof
11/10/2005US20050251871 Novel ubiquitin ligases as therapeutic targets
11/10/2005US20050251870 Csnk1gs as modifiers of the p21 pathway and methods of use
11/10/2005US20050251229 Electromagnetic treatment apparatus and method for angiogensis modulation of living tissues and cells
11/10/2005US20050251046 Probe array producing method
11/10/2005US20050250938 Isolated gamma coixin promoter comprising specified nucleic acid sequence
11/10/2005US20050250937 Nucleotide sequences coding enzymatic polypeptide for use in the generation of lysine
11/10/2005US20050250936 Modified TGF-beta superfamily proteins
11/10/2005US20050250934 synthetic peptide conjugate compositions for the treatment of immunoglobulins (IgE)-mediated allergic diseases by active immunization
11/10/2005US20050250933 Vaccines
11/10/2005US20050250786 PNA monomer and precursor
11/10/2005US20050250785 PNA monomer and precursor
11/10/2005US20050250727 Use of immunomodulating agents
11/10/2005US20050250723 Immunostimulation by chemically modified RNA
11/10/2005US20050250722 FcgammaRIIA-specific nucleic acid interference
11/10/2005US20050250721 A replication-defective adenoviral or adeno-associated viral vector; gene therapy for congestive heart failure
11/10/2005US20050250718 Pharmaceutical- or gene-carrier compositions with reduced hemagglutinating activity
11/10/2005US20050250717 Chromatin remodeling protein as a marker expressed by stromal progenitor cells
11/10/2005US20050250711 Use of macrolides in pest control
11/10/2005US20050250696 Truncated soluble tumor necrosis factor type-I and type-II receptors
11/10/2005US20050250695 Combination PDGF, KGF, IGF, and IGFBP for wound healing
11/10/2005US20050250664 Producing ethanol from starch using amylase variants; artificial sweetners and flavor enhancers
11/10/2005US20050250221 With the use of magnetic beads; used for analysis of the gene structure or gene sequence; increased total surface area of the magnetic beads, which area is available for binding of the analyte
11/10/2005US20050250208 Control of gene expression
11/10/2005US20050250207 Retrons for gene targeting
11/10/2005US20050250206 Development of DNA probes and immunological reagents specific for cell surface-expressed molecules and transformation-associated genes
11/10/2005US20050250205 Use of associations between at least one nucleic sequence polymorphism of the sh2 gene and at least one seed quality characteristic in plant selection methods
11/10/2005US20050250203 Embryonic or stem-like cell lines produced by cross species nuclear transplantation
11/10/2005US20050250200 Testing microreactor, testing device and testing method
11/10/2005US20050250199 Multicompartment, miniaturized fluidic apparatus analytical for use in propagation of DNA sequences; gene expression analysis
11/10/2005US20050250197 Microinjection device and microinjection method
11/10/2005US20050250196 Recombinant microorganisms expressing an oligosaccharide receptor mimic
11/10/2005US20050250192 Bacillus which produce lactic acid
11/10/2005US20050250186 Methods and compositions for modulating telomerase reverse transcriptase (TERT) expression
1 ... 1914 1915 1916 1917 1918 1919 1920 1921 1922 1923 1924 1925 1926 1927 1928 1929 1930 1931 1932 1933 1934 ... 4023